Piramal Pharma Swings to Rs 5 Crore Q2 Profit from Rs 99 Crore Loss, Revenue Jumps 28%
New Delhi: Piramal Pharma on Thursday reported a consolidated net profit of Rs 5 crore in the July-September period of the current fiscal year.
The pharma company had posted a loss of Rs 99.22 crore in the year-ago period, the company said in a regulatory filing on Tuesday evening.
Revenue from operations rose to Rs 2,617.06 crore in the second quarter of the ongoing fiscal year, up from Rs 2,043.72 crore in the year-ago period, the Mumbai-based firm said.
Its total expenses, too, grew to Rs 2,589.10 crore in the September quarter from Rs 2,170.29 crore in the corresponding period of the previous year.
Piramal Pharma shares settled 1.69 per cent higher at 198.45 apiece on the BSE.
Next Story